WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, announced today that it received approval from the ...
Active-Investors.com is currently working on the research report for Apollo Endosurgery, Inc. (NASDAQ: APEN), which also belongs to the Healthcare sector as the Company Corindus Vascular Robotics. Do ...
Breakfast symposium and conference activities to highlight capabilities of vascular robotic technology and advancements in automation and remote treatment • “Clinical Review” presented by Ehtisham ...
WALTHAM, Mass., Corindus Vascular Robotics, Inc., a leading developer of precision vascular robotics, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) ...
WALTHAM, Mass., Corindus Vascular Robotics, Inc., a leading developer of precision vascular robotics, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration ...
GOTHENBURG, Sweden, Nov. 9, 2022 /PRNewswire/ -- Mentice, a world leader in simulation solutions for image-guided interventional therapies, announced today that Siemens Healthineers China is ...
WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, today reported financial results for its first quarter ...
Case broadcast live to thousands of EuroPCR attendees from Clinique Pasteur in France Corindus Vascular Robotics, Inc. ("Corindus" or the "Company") (NYSE American: CVRS), a leading developer of ...
GOTHENBURG, Sweden, Nov. 9, 2022 /PRNewswire/ -- Mentice, a world leader in simulation solutions for image-guided interventional therapies, announced today that Siemens Healthineers China is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results